Chiome Bioscience Inc.

4583・Growth Market・Pharmaceuticals

Official website

Chiome Bioscience Inc.

4583・Growth Market・Pharmaceuticals

Official website

Chiome Bioscience Inc.4583

Reference Indicators

Market Cap

52¥100M

P/E (Forecast)

—

P/B

4.4x

Dividend Yield (Forecast)

0.00%

ROE

-88.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	712	630	682	780	593
Cost of Sales	290	281	283	347	237
Gross Profit	422	348	398	432	355
SG&A Expenses	1,756	1,607	1,603	1,463	1,335
Operating Income	-1,334	-1,258	-1,205	-1,030	-979
Non-operating Income	13	20	1	29	2
Non-operating Expenses	8	5	13	18	11
Ordinary Income	-1,329	-1,243	-1,217	-1,019	-989
Extraordinary Income	12	5	2	1	9
Extraordinary Losses	149	—	—	—	—
Pre-tax Income	-1,466	-1,237	-1,215	-1,017	-979
Income Taxes	13	5	5	3	3
Net Income	-1,479	-1,242	-1,220	-1,020	-982
EBITDA	-1,331	-1,257	-1,203	-1,029	-976
Gross Margin	59.3%	55.3%	58.4%	55.4%	59.9%
Operating Margin	-187.2%	-199.5%	-176.6%	-132.0%	-165.1%
ROA	-63.3%	-56.1%	-69.7%	-41.3%	-56.9%
ROE	-79.7%	-69.9%	-107.0%	-53.4%	-88.7%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
創薬事業	0	-776	0.0%
創薬支援事業	593	355	59.9%